Role of multidrug resistance in tumors of the genitourinary tract (Q40646603)

22 September 2017

1 reference

title

Role of multidrug resistance in tumors of the genitourinary tract (English)

1 reference

22 September 2017

main subject

multiple drug resistance

1 reference

Theyer G

1

1 reference

22 September 2017

Hamilton G

series ordinal

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 December 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

44

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

942-950

1 reference

Chemotherapy for urothelial tract malignancies: breaking the deadlock

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

MDR1 (P-glycoprotein) gene expression--implications for resistance modifier trials

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Modulation of multidrug resistance: at the threshold

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Resistance to cytostatic drugs at the cellular level

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

1 reference

7 January 2021

Pleiotropic, multidrug-resistant phenotype and P-glycoprotein: a review

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Does P-Glycoprotein Predict Response to Chemotherapy, and If So, Is There a Reliable Way to Detect It?

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistance

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

MDR1 gene expression and treatment outcome in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Reversal of multidrug resistance in breast cancer: many more open questions than answers.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Expression of a multidrug resistance gene in esophageal adenocarcinoma. Correlation with response to chemotherapy and comparison with gastric adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Clinical trials of agents that reverse multidrug resistance. A literature review

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Chemosensitisation effect of verapamil and cyclosporin A in vitro is reduced under acidic pH conditions.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

DNA topoisomerase poisons as antitumor drugs

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

DNA topoisomerase I and II in cancer chemotherapy: update and perspectives

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Cross-resistance patterns related to glutathione metabolism in primary human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Monoclonal antibodies to glutathione S-transferase pi-immunohistochemical analysis of human tissues and cancers

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Immunohistochemical detection of P-glycoprotein and GSTP1-1 in testis cancer

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Elevated Expression of P-Glycoprotein in Kidney and Urinary Bladder Cancers

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Measurement of Multidrug-Resistance Messenger RNA in Urogenital Cancers; Elevated Expression in Renal Cell Carcinoma is Associated with Intrinsic Drug Resistance

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Evaluation of multiple drug resistance in human bladder cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Intravesical therapy with adriamycin plus verapamil in patients with superficial bladder cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Management of relapsing disease in prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Multidrug resistance gene (MDR1) expression in human brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Drug-target interactions: only the first step in the commitment to a programmed cell death?

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

p53 Protein Accumulation and Gene Mutation in the Progression of Human Prostate Carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

The effect of verapamil on the pharmacokinetics of adriamycin.

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(94)80191-6

7 January 2021

10.1016/S0090-4295(94)80191-6

Identifiers

DOI

1 reference

release_kkdahpdrxba5lkm7y3jufxgqny

22 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kkdahpdrxba5lkm7y3jufxgqny

24 November 2022

mapped directly with Wikidata item

1 reference